Todd Thomson - Director, 16.4% Owner at Actuate Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 16.4% Owner
Stock Symbol
ACTU on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Todd Thomson since 12/23/2023

Holdings reported by Todd Thomson for Actuate Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.18M Aug 14, 2024 By KVP II, L.P.
Common Stock 873K Aug 14, 2024 By KVOI, L.P.
Common Stock 322K Aug 14, 2024 By Kairos SPV Fund, LLC
Common Stock 255K Aug 14, 2024 By Kairos-Actuate SPV, L.P.
Non-Qualified Stock Options 15K Aug 12, 2024 Direct Common Stock
Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVP II, L.P. Common Stock
Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVOI, L.P. Common Stock
Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos SPV Fund, LLC Common Stock
Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVOI, L.P. Common Stock
Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVP II, L.P. Common Stock
Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos-Actuate SPV, L.P. Common Stock
Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos SPV Fund, LLC Common Stock
Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos-Actuate SPV, L.P. Common Stock
Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos SPV Fund, LLC Common Stock
Warrant (Right to Buy) 0 Aug 14, 2024 By KVP II, L.P. Common Stock

Transactions reported by Todd Thomson for Actuate Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.